AXON has risen roughly 40% in the last 3 months, similar in spirit to Palantir’s past run. Retail traders may continue to buy the stock for momentum regardless of ethical concerns, creating upside pressure. Potential momentum-driven long opportunity, but only for traders comfortable with governance/reputational risk. The Epstein co-founder claim may be inaccurate; overbought conditions could trigger a pullback; bad headlines could hurt sentiment.
AXON has risen roughly 40% in the last 3 months, similar in spirit to Palantir’s past run. Retail traders may continue to buy the stock for momentum regardless of ethical concerns, creating upside pressure. Potential momentum-driven long opportunity, but only for traders comfortable with governance/reputational risk. The Epstein co-founder claim may be inaccurate; overbought conditions could trigger a pullback; bad headlines could hurt sentiment.